The new Fumo-V™ ONE Strip Test from Waters Corporation can test for fumonisin and other prevalent mycotoxins in finished animal feed and pet food in less than ten minutes.
USDA’s Pesticide Data Program Annual Summary for 2022 shows that more than 99 percent of products sampled through PDP had residues below tolerances set by EPA. However, testing for persistent environmental contaminants that are no longer used as pesticides in the U.S. showed the presence of certain banned chemicals in some foods.
The European Food Safety Authority (EFSA) has introduced TKPlate, a new platform that can model and predict the toxicity and toxicokinetics of chemicals used in foods, which will help reduce the amount of animal testing used in food safety assessments.
On November 1, 2023, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) will begin a one-year sampling program of domestic beef, pork, and Siluriformes fish (commonly referred to as catfish) to determine levels of dioxins and dioxin-like compounds.
The vast majority of food on the market in Canada meets standards for chemical residues, according to a Canadian Food Inspection Agency (CFIA) report summarizing sampling activities conducted in 2020–2021.
After reviewing its sampling and testing programs, USDA’s Food Safety and Inspection Service (FSIS) will implement changes to its sampling programs for Fiscal Year (FY) 2024. The agency also explained its sampling and testing priorities.
The U.S. Department of Agriculture has launched a new exploratory sampling program for antibiotic residues in cattle that are claimed to be raised without antibiotics.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) has developed an innovative method for beef muscle samples that uses modern chemistry instrumentation for quantifying chemical residues.
This article discusses the consumer and regulatory drivers of the current focus on heavy metals in foods for babies and young children, and also explores the congressional investigation and FDA's subsequent Closer to Zero effort. It also discusses the latest developments and what moves can be expected next from FDA.
RSS
